BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Healthtrust Education - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Healthtrust Education
X-ORIGINAL-URL:https://education.healthtrustpg.com
X-WR-CALDESC:Events for Healthtrust Education
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210921
DTEND;VALUE=DATE:20210922
DTSTAMP:20260505T031711
CREATED:20210917T144332Z
LAST-MODIFIED:20210927T185414Z
UID:10002837-1632182400-1632268799@education.healthtrustpg.com
SUMMARY:On-Demand Program: "Personal Protective Equipment: What You Don’t Know Can Hurt You"
DESCRIPTION:3M*\, Aspen Surgical* and Pfiedler Education present…“Personal Protective Equipment: What You Don’t Know Can Hurt You” \nEvery healthcare worker who cares for patients\, or supports the staff who care for patients\, will most likely need to use personal protective equipment (PPE) at some point during their work duties. Healthcare workers need to protect themselves from transmissible diseases\, especially during the COVID-19 pandemic. Because\, unfortunately\, transmissible diseases are not going away\, it is important to learn how to don and doff PPE and to do it correctly every single time. \nThis learning activity will illustrate the proper use of PPE along with helping the learner to understand the rationale behind each action. \n\nDescribe the types of PPE\, differentiating between the levels of gowns and mask options that are available\nDiscuss standard precautions along with the three major categories of disease transmission and appropriate PPE for each\nSummarize the proper use of PPE and major points of donning and doffing to ensure maximum protection\n\nThis eLearning program is available at no cost. \nFunding provided by 3M*  |  Aspen Surgical* \nContinuing Nursing and Allied Health Education provided by Pfiedler Education.Earn 1 CE.CA:1.0\, CBSPD:1.0\, IAHCSM:1.0\, NCCT:1.0 \nQuestions? Contact: registrar@pfiedlerenterprises.com or call 720-748-6144 \n* NOTE: This is an industry resource and/or contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/on-demand-program-personal-protective-equipment-what-you-dont-know-can-hurt-you/2021-09-21/
CATEGORIES:Healthcare Executives,Lab,Nursing,Physicians,Respiratory
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210429T110000
DTEND;TZID=America/Chicago:20210429T120000
DTSTAMP:20260505T031711
CREATED:20210323T173126Z
LAST-MODIFIED:20210323T173147Z
UID:10000693-1619694000-1619697600@education.healthtrustpg.com
SUMMARY:"What Every Nurse Needs to Know about High-Resolution Manometry"
DESCRIPTION:Initiatives Webinar series with support from Medtronic* & Saxe Communications present….“What Every Nurse Needs to Know about High-Resolution Manometry” \nEsophageal high-resolution manometry (HRM) is the current state-of-the-art diagnostic tool to evaluate esophageal motility patterns. HRM measures intraluminal pressure activity in the gastrointestinal tract using a series of closely spaced pressure sensors. In this webinar\, we will discuss how the procedure is performed\, which patient population would benefit from this procedure\, how to interpret the results and lastly\, the clinical applicability of the test results. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDefine High-Resolution Manometry (HRM)\nList the indications for the procedure\nIdentify normal and abnormal findings\n\nPresenter: \nJanice Freeman\, RN III\, BSN\, CCRC\, CFER  |  Esophageal Function Laboratory Clinical Coordinator  |  Medical University of South Carolina \nTarget Audience:  Nurses \nContinuing Education for Nurses. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by the California Board of Nursing\, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032. \nSupport for this educational activity provided from Medtronic*. \nQuestions should be addressed to webinar@saxecommunications.com \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/what-every-nurse-needs-to-know-about-high-resolution-manometry/
CATEGORIES:Lab,Nursing
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210330T120000
DTEND;TZID=America/Chicago:20210330T130000
DTSTAMP:20260505T031711
CREATED:20210223T184022Z
LAST-MODIFIED:20210223T184022Z
UID:10002621-1617105600-1617109200@education.healthtrustpg.com
SUMMARY:"A Laboratorian’s Point of View - Interview With an Industry Expert"
DESCRIPTION:The Joint Commission* presents... “A Laboratorian’s Point of View – Interview With an Industry Expert” \nLaboratory professionals managed to battle and emerge successfully from an unprecedented healthcare challenge. Hear from laboratorian Dr. Rodney Rhodes as he shares his viewpoints\, lessons learned and strategies for the future in an interactive discussion with our team. \nPresenter: \nRodney Rhodes\, Ph.D. |  Professor & Chair  |  Clinical Laboratory Science (CLS) Program  |  College of Health Professions  |  Texas State University \nTarget Audience: Lab \nIt does not appear CE credit is associated with this session. \nQuestions should be directed to the Joint Commission at 630.792.5817. \n* NOTE: This is an industry-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/a-laboratorians-point-of-view-interview-with-an-industry-expert/
CATEGORIES:Lab
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210326T120000
DTEND;TZID=America/Chicago:20210326T133000
DTSTAMP:20260505T031711
CREATED:20210322T181816Z
LAST-MODIFIED:20210322T181939Z
UID:10000651-1616760000-1616765400@education.healthtrustpg.com
SUMMARY:"COVID-19 and Beyond: Quelling the Pandemic using Diagnostics\, Therapeutics & Vaccinations"
DESCRIPTION:O&M* presents…“COVID-19 and Beyond: Quelling the Pandemic using Diagnostics\, Therapeutics & Vaccinations” \nThis webinar program will review the important role that a combination approach of diagnostics\, therapeutics and vaccinations play in reducing the ongoing COVID-19 pandemic. The program will also address the “elephant in the room” which is the significant consequences of the prolonged response on the resiliency of healthcare providers. Finally\, the webinar will discuss the evolving evidence-based treatment guidelines for COVID-19 and their application in both inpatient and outpatient settings. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDiscuss the current treatment guidelines for COVID-19 in both inpatient and outpatient settings\nReview the role of diagnostics\, therapeutics and vaccinations in quelling the ongoing Pandemic threat\nDiscuss the core elements of future preparedness and maintaining resiliency in healthcare providers despite challenging circumstances\n\nPresenter: \n \nDr. Hudson Garrett\, Jr.\, Ph.D.\, MSN\, MPH\, FNP-BC\, IP-BC\, CPPS\, CFER\, FNAP  |  The President and CEO of Community Health Associates\, LLC  |  Adjunct Professor of Medicine  |  University of Louisville School of Medicine \nTarget Audience:  Nurses \nContinuing Education:  1.5 CE Contact Hours for RNs.  Terri Goodman & Associates is approved as a provider of nursing continuing professional development by the New Mexico Nurses Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Certificate of Completion available to all participants. \nFunded by Owens & Minor* \n*NOTE: This is a contracted supplier and/or industry-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as an endorsement of any particular supplier\, product\, service\, drug\, brand or approach
URL:https://education.healthtrustpg.com/calendar/covid-19-and-beyond-quelling-the-pandemic-using-diagnostics-therapeutics-vaccinations/
CATEGORIES:Lab,Nursing
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210318T123000
DTEND;TZID=America/Chicago:20210318T133000
DTSTAMP:20260505T031711
CREATED:20210301T135832Z
LAST-MODIFIED:20210301T140012Z
UID:10002625-1616070600-1616074200@education.healthtrustpg.com
SUMMARY:"COVID-19 Q&A Webinar for Laboratory Accreditation"
DESCRIPTION:The Joint Commission* presents... “COVID-19 Q&A Webinar for Laboratory Accreditation” \nThe Joint Commission hosts a live question and answer session relevant to the public health emergency. Topics to be covered include: \n\nInfection control practices\nEnvironment of care/life safety\nCMS 1135 waivers\nEffects of COVID-19 on Joint Commission survey efforts\n\nPresenters: \n\nRobert Campbell\, PharmD\, BCSCP  |  Director\, Clinical Standards Interpretation Hospital/Ambulatory Programs  |  Director\, Medication Management  |  The Joint Commission\nSylvia Garcia-Houchins\, MBA\, RN\, CIC  |  Director  |  Infection Prevention and Control  |  The Joint Commission\nBridget Kapnick\, MPH  |  Associate Director\, Accreditation  |  Accreditation and Certification Operations  |  The Joint Commission\nHerman A. McKenzie\, MBA\, CHSP  |  Director of Engineering  |  Standards Interpretation Group  |  The Joint Commission\nMaura Naddy\, MSN\, RNC-OB\, CJCP  |  Associate Director  |  Standards Interpretation Group  |  The Joint Commission\nAmy Null  |  Surveyor  |  Laboratory Accreditation Program  |  The Joint Commission\nBarbara Schwarzer\, MHA\, MSOL\, MT(ASCP)\, CPHQ  |  Field Director   |  The Joint Commission\nCherie Ulaskas\, MT(ASCP)\, MA  |  Associate Director  |  Standards Interpretation Group  |  The Joint Commission\nTiffany Wiksten\, MSN\, RN\, CIC  |  Associate Director  |  Standards Interpretation Group  |  The Joint Commission\n\nTarget Audience: Anyone interested \nIt does not appear CE credit is associated with this session. \nQuestions should be directed to the Joint Commission at 630.792.5291; certification@jointcommission.org \n* NOTE: This is an industry-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/covid-19-qa-webinar-for-laboratory-accreditation/
CATEGORIES:Healthcare Executives,Lab,Nursing,Other
ATTACH;FMTTYPE=image/jpeg:https://education.healthtrustpg.com/wp-content/uploads/2020/05/Germ_coronavirus-graphic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20201210T110000
DTEND;TZID=America/Chicago:20201210T143000
DTSTAMP:20260505T031711
CREATED:20201027T184524Z
LAST-MODIFIED:20201027T185102Z
UID:10002571-1607598000-1607610600@education.healthtrustpg.com
SUMMARY:"Healthcare-Associated Infection Mini-Summit"
DESCRIPTION:Sepsis Alliance Institute* presents…“Healthcare-Associated Infection Mini-Summit” a virtual half-day conference \nOne in every 31 patients has at least one healthcare-associated infection (HAI) each day.  Despite attention and improvements\, healthcare-associated infections (HAIs) remain a challenge to healthcare professionals.  Register for the “Healthcare-Associated Infection Mini-Summit” to learn from subject matter experts about the most current clinical knowledge on HAIs\, their recommendations on infection prevention and treatment\, as well as antibiotic stewardship.  Each lecture presentation will include a question and answer session with the presenter. \nTopics include: \n\nventilator- and non-ventilator associated pneumonia\nC. difficile\nintra-abdominal infection\ncardiac device infection\nprosthetic joint infection\n\nModerator: \n \nCindy Hou\, DO\, MA\, MBA\, FACOI\, FACP\, FIDSA  |  Infection Control Officer  |  Jefferson Health New Jersey \nConfirmed Presenters: \n \nCDR Alice Guh\, M.D.\, MPH  |  U.S. Public Health Service Medical Officer  |  Division of Healthcare Quality Promotion (DHQP)  |  Centers for Disease Control and Prevention (CDC) \n \nDian Baker\, Ph.D.\, NP\, RN  |  Professor\, School of Nursing  |  California State University\, Sacramento \nTarget Audience: Nurses \nContinuing Education: 3.6 RN CE Contact Hours Available. Sepsis Alliance is a provider approved by the California Board of Registered Nursing\, Provider Number CEP17068 for 3.6 contact hours. \nThis event is supported by an unrestricted medical education grant from Merck* to Sepsis Alliance. All event speakers are participating on a voluntary basis; participation does not indicate a relationship between the speakers and Merck or other Sepsis Alliance supporters.  \n* NOTE: This is a supplier and/or industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/healthcare-associated-infection-mini-summit/
CATEGORIES:Lab,Nursing,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200917T130000
DTEND;TZID=America/Chicago:20200917T140000
DTSTAMP:20260505T031711
CREATED:20200914T145048Z
LAST-MODIFIED:20200914T145048Z
UID:10000521-1600347600-1600351200@education.healthtrustpg.com
SUMMARY:"Testing and Treatment of 2020-2021 Seasonal Influenza During the  COVID-19 Pandemic"
DESCRIPTION:The CDC Clinician Outreach and Communication Activity (COCA)* presents...”Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic” \nInfluenza surveillance data reported to the World Health Organization’s FluNet platform from three Southern Hemisphere countries (Australia\, Chile\, and South Africa) indicated low influenza activity during June through August 2020\, months that comprise the typical Southern Hemisphere influenza season. The low influenza activity observed in the Southern Hemisphere might reflect the impact of non-pharmaceutical interventions implemented to reduce the spread of SARS-CoV-2\, the virus that causes COVID-19. However\, it is not possible to predict influenza activity or the severity of the upcoming influenza season in the United States with the potential for co-circulation of influenza viruses and SARS-CoV-2. While vaccination remains the best way to prevent influenza\, antiviral medications are an essential adjunct to vaccination—especially for treating outpatients with suspected or confirmed influenza\, in persons at high risk for influenza complications\, in those with progressive disease\, and hospitalized influenza patients.\nDuring this COCA call\, clinicians will hear an overview of CDC’s recommendations for health care providers regarding influenza diagnostics and the use of antiviral medications for the 2020-2021 influenza season\, including considerations during the ongoing COVID-19 pandemic. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nReview influenza activity since the onset of the COVID-19 pandemic.\nProvide background on influenza tests and antivirals for influenza.\nDescribe influenza testing guidance for patients with acute respiratory illness for the 2020-2021 season\, including during community co-circulation of influenza viruses and SARS-CoV-2.\nDescribe antiviral treatment recommendations for patients with suspected or confirmed influenza for the 2020-2021 season\, including during community co-circulation of influenza viruses and SARS-CoV-2.\n\nPresenters: \nAngela Campbell\, MD\, MPH\, FIDSA\, FPIDS Medical Officer\, Influenza Division  |  National Center for Immunization & Respiratory Diseases  |  Centers for Disease Control & Prevention \nTimothy Uyeki\, MD\, MPH\, MPP\, CAPT\, USPHS   |Chief Medical Officer\, Influenza Division  |  National Center for Immunization & Respiratory Diseases  |  Centers for Disease Control & Prevention \nContinuing Education information: To receive continuing education (CE) for WC2922-091720 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic\, Thursday\, September 17\, 2020\, please visit TCEO and follow these 9 Simple Steps by Monday\, October 19\, 2020.  To receive continuing education (CE) for WD2922-091720 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic\, Thursday\, September 17\, 2020\, (Web on Demand)\, please visit TCEO and follow these 9 Simple Steps by Thursday\, October 20\, 2022. \nCME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.  The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. \nCNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 1.0 contact hour. \nCEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program. \nCECH: Sponsored by the Centers for Disease Control and Prevention\, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing\, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 091720. \nCPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-20-049-L04-P and enduring JA4008229-0000-20-050-H04-P course category. \nThis activity has been designated as Knowledge-Based. \nOnce credit is claimed\, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor. For Certified Public Health Professionals (CPH)\, The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credit for this program. \nAAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession. \nDISCLOSURE: In compliance with continuing education requirements\, CDC\, our planners\, our presenters\, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products\, suppliers of commercial services\, or commercial supporters. \n* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/testing-and-treatment-of-2020-2021-seasonal-influenza-during-the-covid-19-pandemic/
CATEGORIES:Healthcare Executives,Lab,Nursing,Pharmacy,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200917T120000
DTEND;TZID=America/Chicago:20200917T130000
DTSTAMP:20260505T031711
CREATED:20200819T173714Z
LAST-MODIFIED:20201106T151042Z
UID:10002502-1600344000-1600347600@education.healthtrustpg.com
SUMMARY:"Hypertensive Disorders of Pregnancy"
DESCRIPTION:  \nDownload a copy of this content. \nSupporting Documents & Procedures Checklists \nPlease Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. \nHealthTrust presents…“Hypertensive Disorders of Pregnancy” (Part 2 Update in the Maternal Morbidity & Mortality series) \nDespite a worldwide trend toward improvement in maternal morbidity and mortality\, rates in the U.S. have surged in recent years. Specifically\, the unacceptable rates of preventable adverse events in childbirth are topping 50 percent. A major reason for this tragic result is poor recognition and appropriate treatment of hypertensive disorders during pregnancy. This program will review the four major hypertensive disorders of obstetrics and focus on the rapid diagnosis and treatment of hypertensive emergencies—a major cause of maternal deaths. A tailored\, multi-disciplinary approach including contributions from pharmacists\, nurses and lab clinicians is essential for successful outcomes in the treatment of hypertensive disorders. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDescribe the four types of hypertension that can complicate pregnancy\nDiscuss maternal and fetal complications that can result from hypertensive disorders of pregnancy\nOutline treatment strategies for the management of hypertensive emergencies in pregnancy\nIdentify the benefits of utilizing an evidence-based care team approach to aid patients with hypertensive disorders\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.  FACOG  |  Chairman of the Department of Obstetrics & Gynecology  |  Moses Taylor Hospital \nTarget Audience: Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education Information: 1.0 contact hours approved for Nurses\, Pharmacists and Lab professionals. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-20-077-L04-P. Pfiedler is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. The activity is approved for 1 hour of continuing education credit to pharmacists\, nurses and lab professionals who attend the webinar and complete the online evaluation. California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing\, Provider Number CEP 14944 for 1.0 contact hour. \nNote about CE credit: If you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting. \nSearch the calendar for previous topics in the updated Maternal Morbidity & Mortality Series: \n\nAugust 19\, 2020 – Code Crimson: Massive Transfusion Protocol\n\nEffective June 1\, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.  A participant\, sponsor\, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied\, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
URL:https://education.healthtrustpg.com/calendar/5110/
CATEGORIES:Hematology,Lab,Nursing,Pharmacy,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200901T120000
DTEND;TZID=America/Chicago:20200901T130000
DTSTAMP:20260505T031711
CREATED:20200817T181115Z
LAST-MODIFIED:20200817T181302Z
UID:10002484-1598961600-1598965200@education.healthtrustpg.com
SUMMARY:"Sepsis: Silent Threat Brought to Light"
DESCRIPTION:Radiometer & acutecaretesting.org* present…“Sepsis: Silent Threat Brought to Light” \nWith the rapid global spread of the confirmed cases of novel coronavirus SARS-CoV-2\, COVID-19 has impacted the healthcare system across the continuum of care. It becomes vital to identify signs of sepsis early\, and initiate prompt treatment when diagnosed. Timely intervention may save lives and organ function. \nRapid diagnosis of sepsis is paramount to reduce mortality  |  This webinar will provide updates on prevalence on both neonatal and adults population\, but also outline the most recent international\, U.S. and Canadian guidelines for sepsis diagnosis and management. With a focus on the importance of the role of clinical laboratory testing\, including lactate\, PCT\, CRP\, it will discuss their effectiveness and with other biomarkers in both diagnosis and monitoring of sepsis\, including the pre-analytical and analytical requirements for accurate testing. The webinar will also include a brief discussion of the novel approaches to diagnosis and treatment of sepsis during COVID-19. \nLearning Objectives: \n\nReview the prevalence and impact on neonatal and adults patient healthcare\nOutline the most recent international\, U.S. and Canadian definitions and guidelines for treatment and management of sepsis\nExamine the importance of accurate clinical laboratory testing in the diagnosis and monitoring of sepsis treatment: Lactate\, PCT\, CRP and others\nDiscuss the effectiveness of PCT in reducing the cost of antibiotics stewardship\nReview novel approaches to diagnosis and treatment of sepsis during COVID-19\n\nPresenter: \n \nMartha E. Lyon\, Ph.D.\, DABCC  |  FACB Clinical Biochemist Royal University Hospital  |  Saskatchewan Health Authority  |  Saskatoon\, Saskatchewan\, Canada \nTarget Audience: Laboratorians\, Clinical chemists\, Pathologists\, Lab managers and directors\, Point of care coordinators\, Respiratory therapists\, Nurses\, NICU clinicians\, ICU clinicians\, ED clinicians \nContinuing education information: \n\nOne P.A.C.E. credit-hour will be provided for this session. Radiometer is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program\nThis session is approved for 1 Florida Laboratory CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563\nThis program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC)\nThis program has been approved by the American Association of Critical-Care Nurses (AACN) for 1.00 CERPs\, Synergy CERP Category A\, File number 23240\n\nQuestions should be directed to Radiometer \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/sepsis-silent-threat-brought-to-light/
CATEGORIES:Lab,Nursing,Other,Respiratory
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200820T110000
DTEND;TZID=America/Chicago:20200820T120000
DTSTAMP:20260505T031711
CREATED:20200805T194642Z
LAST-MODIFIED:20201106T151532Z
UID:10000457-1597921200-1597924800@education.healthtrustpg.com
SUMMARY:"Code Crimson: Massive Transfusion Protocol"
DESCRIPTION:  \nDownload a copy of this content. \nSupporting Documents & Procedures Checklists \nPlease Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. \nHealthTrust presents… “Code Crimson: Massive Transfusion Protocol” \nThe U.S. rate of severe maternal morbidity at delivery\, as defined by a variety of conditions and procedures\, increased 45 percent from 2006 through 2015. The cause of this adverse trend is complex and multi-factorial. A significant place to start in combating the current epidemic of maternal mortality in the United States is appropriately addressing maternal hemorrhage. The presenter offers an evidenced-based approach to saving maternal lives when the inevitable life-threatening hemorrhage does occur. \nLearning Objectives for Nurses\, Pharmacists & Lab clinicians  |  At the end of this session\, participants should be able to: \n\nDefine risk factors which contribute to catastrophic maternal hemorrhage\nRecall why massive transfusion protocols are physiologic and effective\nExplain the benefits of utilizing an evidence-based care team approach to aid patients in extremis\nReview the Joint Commission provision of care\, treatment and service standards for Maternal safety regarding hemorrhage.\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.  FACOG  |  Chairman of the Department of Obstetrics & Gynecology  |  Moses Taylor Hospital \nTarget Audience: Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education Information: 1.0 contact hours approved for Pharmacists\, Nurses and Lab professionals. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-20-076-L04-P. Pfiedler is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. The activity is approved for 1 hour of continuing education credit to pharmacists\, nurses and lab professionals who attend the webinar and complete the online evaluation. California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing\, Provider Number CEP 14944 for 1.0 contact hour. \nNote about CE credit: If you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting. \nWatch for upcoming topics in the Maternal Morbidity & Mortality Series: \n\nSept. 17\, 2020 – Four Types of Hypertension in Obstetrics\n\nEffective June 1\, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.  A participant\, sponsor\, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied\, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
URL:https://education.healthtrustpg.com/calendar/save-the-date-code-crimson-massive-transfusion-protocol-2/
CATEGORIES:Lab,Nursing,Pharmacy
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200519T140000
DTEND;TZID=America/Chicago:20200519T150000
DTSTAMP:20260505T031711
CREATED:20200512T225326Z
LAST-MODIFIED:20200512T225326Z
UID:10002443-1589896800-1589900400@education.healthtrustpg.com
SUMMARY:"Blood Shortage & Coagulopathy in the COVID-19 World"
DESCRIPTION:Z-Medica* presents…”Blood Shortage & Coagulopathy in the COVID-19 World” \nThis clinical forum\, driven by a diverse panel of trauma surgeons\, will focus on the topic of blood shortage and coagulopathy in a COVID-19 world and also other implications and challenges created due to the pandemic. We welcome you to register for the webinar event on May 19\, 2020. \nPresenters: \n \nA. Britt Christmas\, M.D.\, FACS  |  Professor of Surgery\, Atrium Health   |  Vice Chief & Associate Medical Director of Trauma   |  President of EAST \n \nKari Jerge\, M.D.   |  Assistant Professor of Surgery   |  Loma Linda University Department of Surgery  |  Riverside University Health System Medical Center \n \nMatt Martin\, M.D.\, FACS\, FASMBS   |  Colonel (Retired)\, Medical Corps\, US Army Trauma Research & Education Director  |  Department of Surgery\, Scripps Mercy Medical Center \n \nMartin A. Schreiber\, M.D.\, FACS\, FCCM   |  Oregon Health & Science University   |  Professor of Surgery\, Division of Trauma\, Critical  & Acute Care Surgery  |  School of Medicine Chair\, TCAA \n \nJoe DuBose\, M.D.\, FACS\, FCCM\, FSVS\, RPVI  |  Colonel\, United States Air Force Medical Corps   |  Professor of Surgery\, Uniformed Services  |  University of tile Health Sciences   |  Professor of Surgery  | Volunteer University of Maryland R. Adams \n \nJoshua P. Hazelton\, DO\, FACS\, FACOS   |Chief\, Section of Trauma Division of Trauma\, Acute Care & Critical Care Surgery  |  Department of Surgery Penn State Milton s. Hershey\nMedical Center \nQuestions should be addressed by Z-Medica   |  203-774-7921 \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular upplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/blood-shortage-coagulopathy-in-the-covid-19-world/
CATEGORIES:Hematology,Lab,Nursing,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200317T130000
DTEND;TZID=America/Chicago:20200317T140000
DTSTAMP:20260505T031711
CREATED:20200309T201424Z
LAST-MODIFIED:20200330T124951Z
UID:10002416-1584450000-1584453600@education.healthtrustpg.com
SUMMARY:Novel Coronavirus (COVID-19) Update
DESCRIPTION:HealthTrust hosted a live webinar event on March 17: “Novel Coronavirus (COVID-19) Update” \n \n \nLinks to important resources from the CDC\, WHO and more… \nOn the last day of 2019\, a pneumonia of unknown cause was detected in Wuhan\, China\, and first reported to the World Health Organization (WHO). The virus has continued to spread and the outbreak declared a “public health emergency of international concern” on Jan. 30\, 2020. The WHO has since announced a name for the new coronavirus disease: COVID-19. While news reports and online platforms continue to post hourly on COVID-19\, how much can be attributed to reputable sources is not easily identifiable. \nJoin HealthTrust for a brief overview of current state as reported by WHO and the CDC\, key elements to identify and contain the virus\, and information on available resources to address this disease in your health system and community. An infectious disease physician from the HealthTrust Physician Advisor program will offer some real-world examples of how facilities are applying CDC guidelines to their treatment plans. Attendees will be provided with links to reputable resources that are updating their sites as new information is available. \nIntroduction by:\n\n\nJohn Young M.D.\, MBA\nHealthTrust Chief Medical Officer \n\nPresenters:\n\n\n \nKaren Bush\, MSN\, FNP\, BC\nHealthTrust Director of Clinical Research & Education  \n\n\n \nChris French\, PharmD\, MBA\nHealthTrust Director of Pharmacy Operations \n\n\n \nS. Shaefer Spires\, M.D.\nHealthTrust Physician Advisor & Infectious Disease Specialist at Duke University Hospital \n\n\nThere will be no CE credit associated with this event. \nNote: This webinar & accompanying resource document are for informational purposes only and are not intended to replace individual clinical decision-making\, which is the sole and independent responsibility of the practitioner. HealthTrust expressly disclaims any liability for treatment decisions. Please direct any questions or comments to clinical.research@healthtrustpg.com.
URL:https://education.healthtrustpg.com/calendar/save-the-date-novel-coronavirus-covid-19-update/
CATEGORIES:Healthcare Executives,Lab,Nursing,Pharmacy,Physicians,Respiratory,Supply Chain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200219T140000
DTEND;TZID=America/Chicago:20200219T150000
DTSTAMP:20260505T031711
CREATED:20200116T222314Z
LAST-MODIFIED:20200116T222425Z
UID:10002373-1582120800-1582124400@education.healthtrustpg.com
SUMMARY:“Are You Assessment / Inspection Ready?”
DESCRIPTION:The Grifols Academy of Transfusion Medicine* presents…“Are You Assessment / Inspection Ready?” \nBeing prepared for inspections is a crucial aspect of the clinical laboratory\, especially in the transfusion service. In this presentation\, Mary will review various strategies for inspection readiness as well as discuss tasks laboratories can complete on a routine basis to ensure they are prepared for an inspection. Best practices for several key elements within the laboratory will be discussed such as quality control\, equipment maintenance\, competency assessment\, and deviation management. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nRecognize the most common findings identified during external assessments by different accrediting and regulating organizations\nBecome aware of the different agencies and what deemed status by CLIA means\nOutline actions that can be performed routinely to remain ready for external assessments\nDevelop strategies for performing successful self-assessments\n\nSpeaker: \n \nMary Lieb\, MT(ASCP)SBB\, CQA(ASQ)  |  CAP inspector and AABB assessor with national and international experience \nTarget Audience: Beginner\, intermediate & advanced level technologists\, supervisors\, transfusion medicine specialists & blood bank medical directors \nContinuing Education: \n\n1 hour of P.A.C.E.® and Florida Board of Clinical Laboratory Personnel CE credit is offered to participants.\nEvaluation form will be emailed upon registration. Attendance will be recorded and PACE certificate will be emailed upon return of completed evaluation.\nGrifols is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) P.A.C.E.® program and the Florida Board of Clinical Laboratory Personnel. This free educational event is offered by The Grifols Academy of Transfusion Medicine. Your attendance is not conditional upon any obligation to use\, recommend\, promote\, or purchase Grifols products\, nor is it intended to influence you to do so.\n\nQuestions should be directed to Grifols: TSEC@grifols.com or 833-835-3439. \n*NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/are-you-assessment-inspection-ready/
CATEGORIES:Lab,Other
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190910T120000
DTEND;TZID=UTC:20190910T130000
DTSTAMP:20260505T031711
CREATED:20190820T175233Z
LAST-MODIFIED:20190820T175354Z
UID:10000245-1568116800-1568120400@education.healthtrustpg.com
SUMMARY:"The Role of the Clinical Laboratory in the Diagnosis and Treatment of Sepsis"
DESCRIPTION:Radiometer & acutecaretesting.org* present…“The Role of the Clinical Laboratory in the Diagnosis and Treatment of Sepsis” \nSepsis threatens the lives of up to 30 million people each year worldwide. Inappropriate or delayed treatment allows for disease progression to septic shock and as many as 9 million deaths per year. Recent efforts to reduce mortality have focused on generating definitions of sepsis and related conditions. Despite this\, the incidence of sepsis has increased significantly in the U.S. with hospitalizations and related costs doubling over the last 10 years. \nRapid diagnosis of sepsis is paramount to reduce mortality. This webinar will summarize current guidelines for sepsis diagnosis and management. With a focus on the role of clinical laboratory testing including lactate. It will discuss the utility of lactate and other biomarkers in both diagnosis and monitoring of sepsis including the preanalytical and analytical requirements for accurate testing. The webinar will also include a brief discussion of the most promising emerging biomarkers and diagnostic strategies in sepsis. \nLearning Objectives: \n\nOutline the most recent definitions and guidelines for treatment of sepsis\nExplain the importance of clinical laboratory testing in the diagnosis and monitoring of sepsis treatment\nDiscuss the importance of accurate biomarker testing in the septic patient\nReview novel approaches to diagnosis and treatment of sepsis\n\nPresenter: \n \nAlison Woodworth\, Ph.D.\, DABCC\, FAACC  |  Professor\, Pathology & Laboratory Medicine  |  Director\, Core Clinical Laboratory & Point of Care Testing  |  University of Kentucky Medical Center \nTarget Audience: Laboratory Administrators\, Medical Technologists\, Point of Care Coordinators\, Respiratory Therapists\, Nurses \nContinuing education information: \n\nOne P.A.C.E.® credit-hour will be provided for this session. Radiometer is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.\nThis session is approved for 1 Florida Laboratory CE credit.\nFlorida Board of Clinical Laboratory Personnel approved number: 50-12563\nApplication has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.\n\nQuestions should be directed to Radiometer \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/the-role-of-the-clinical-laboratory-in-the-diagnosis-and-treatment-of-sepsis/
CATEGORIES:Lab,Nursing,Other
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190717T120000
DTEND;TZID=UTC:20190717T130000
DTSTAMP:20260505T031711
CREATED:20190711T231647Z
LAST-MODIFIED:20190711T231647Z
UID:10000296-1563364800-1563368400@education.healthtrustpg.com
SUMMARY:"Clinical Benefits of Blood Gas Testing in Critical Care: Amazing Stories"
DESCRIPTION:Radiometer and acutecaretesting.org* present…“Clinical Benefits of Blood Gas Testing in Critical Care: Amazing Stories” \nIn 1957\, the first blood gas analyzer was developed and it was capable of measuring pH\, pCO2 and pO2.  Since then\, significant technological advancements have enabled the implementation of low specimen volume test menus that include electrolytes\, metabolites and hemoglobin derivations in addition to blood gases and pH. Blood gas analyzers are now routinely used to monitor challenging populations such as critically ill patients.  In this case-based webinar\, the benefits/limitations of monitoring critically ill patients in the clinical laboratory will be discussed and compared with the merits/limitations of blood gas analyzers. \nLearning Objectives: \n\nCompare and contrast specimen volume requirements\, turn-around-time expectations and clinical accuracy between clinical laboratory and blood gas analyzer methods\nDescribe the effect of specimen handling and pneumatic tube transportation on the measurement of blood gases\nIdentify the effect of pre-analytical factors such as lipemia and hemolysis on the measurement of electrolytes using chemistry and blood gas analyzer methods\nCompare and contrast the benefits and limitations of measuring glucose\, hemoglobin/hematocrit and bilirubin using clinical laboratory and blood gas analyzer methods\n\nPresenter: \n \nMartha E. Lyon Ph.D.\, DABCC\, FACB  |  Clinical Biochemist  |  Royal University Hospital  |  Saskatchewan Health Authority\, Saskatoon  |  Saskatchewan\, Canada \nTarget Audience:  Laboratory Administrators\, Medical Technologists\, Point of Care Coordinators\, Respiratory Therapists\, Nurses \nContinuing education information:  \n\nOne P.A.C.E.® credit-hour will be provided for this session. Radiometer is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.\nThis session is approved for 1 Florida Laboratory CE credit.\nFlorida Board of Clinical Laboratory Personnel approved number: 50-12563\nThis program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC).\n\nQuestions should be directed to Radiometer \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/clinical-benefits-of-blood-gas-testing-in-critical-care-amazing-stories/
CATEGORIES:Lab,Nursing,Other,Respiratory
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190626T100000
DTEND;TZID=UTC:20190626T110000
DTSTAMP:20260505T031711
CREATED:20190524T233455Z
LAST-MODIFIED:20190524T233711Z
UID:10000228-1561543200-1561546800@education.healthtrustpg.com
SUMMARY:“The Importance of Procalcitonin for Antimicrobial Stewardship in Patients With Lower Respiratory Tract Infections in the Emergency Department”
DESCRIPTION:bioMérieux* presents…“The Importance of Procalcitonin for Antimicrobial Stewardship in Patients With Lower Respiratory Tract Infections in the Emergency Department” \nThis webinar will explore how using a procalcitonin (PCT) driven protocol in the Emergency Department can aid clinicians in decisions about hospital admission versus treatment in the home setting. Session will look at the existing data on procalcitonin in patients with presumed Lower Respiratory Tract Infections (LRTI) and how antibiotic stewardship teams could use this biomarker in shaping their clinical decisions. Lastly\, presenter will examine what stewardship metrics may be impacted by using a procalcitonin-guided protocol. \nLearning Objectives: \n\nUnderstand the role of procalcitonin (PCT) for acute presentation in the emergency department of lower respiratory tract infection and sepsis\nUnderstand appropriate use of procalcitonin (PCT) and how to interpret pct levels in the emergency department\n\nPresenter: \n \nJohn Boreyko\, PharmD\, BCIDP  |  Co-Director of the Antimicrobial Stewardship Program  |  Clinical Infectious Diseases Pharmacist  |  Duke Regional Hospital \n\n\n\n\n\n\n\n\n\n\nCE credit for Lab will be associated with this offering. LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. Earn 1 Continuing Education credit for attending webinar in its entirety.\n\n\n\n\n\n\n\n\n\nQuestions should be directed to bioMérieux: (800) 682 2666 \n* NOTE: This is a HealthTrust contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach. 
URL:https://education.healthtrustpg.com/calendar/the-importance-of-procalcitonin-for-antimicrobial-stewardship-in-patients-with-lower-respiratory-tract-infections-in-the-emergency-department/
CATEGORIES:Lab
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190424T110000
DTEND;TZID=UTC:20190424T120000
DTSTAMP:20260505T031711
CREATED:20190423T183315Z
LAST-MODIFIED:20190423T183829Z
UID:10001652-1556103600-1556107200@education.healthtrustpg.com
SUMMARY:"Remove the Risk"
DESCRIPTION:The FDA* presents…“Remove the Risk” \nThe FDA is excited to announce the upcoming launch of a new public education campaign to encourage safe disposal of unused opioid pain medicines. Join the FDA to hear about this important new effort and learn what you can do to reduce the chance of accidental or intentional prescription opioid misuse among your constituents\, neighbors\, friends and loved ones. The presenter is the Deputy Center Director for Regulatory Programs  who shares responsibility for overseeing the regulation of research\, development\, manufacture and marketing of prescription\, over-the-counter and generic drugs in the United States. He is committed to ensuring that the benefits of approved drugs outweigh their known risks. \nPresenter: \n \nDouglas Throckmorton\, M.D.  |  Deputy Center Director for Regulatory Programs  |  CDER \nTarget audience: Any discipline \nThere does not appear to be continuing education credit associated with this program. \nQuestions should be directed to the FDA: 301-796-8460 \n* NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/remove-the-risk/
CATEGORIES:Cardiovascular,Central Service,Facilities,Food & Nutrition,Healthcare Executives,Lab,Nursing,Other,Pharmacy,Physicians,Radiology,Respiratory,Sterile Processing,Supply Chain,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190418
DTEND;VALUE=DATE:20190604
DTSTAMP:20260505T031711
CREATED:20190418T195638Z
LAST-MODIFIED:20190418T195758Z
UID:10001650-1555545600-1559606399@education.healthtrustpg.com
SUMMARY:HealthTrust Innovation Grant  |  June 3 deadline
DESCRIPTION:
URL:https://education.healthtrustpg.com/calendar/healthtrust-innovation-grant-june-3-deadline/
CATEGORIES:Cardiovascular,Central Service,Facilities,Food & Nutrition,Healthcare Executives,Lab,Nursing,Other,Pharmacy,Physicians,Radiology,Respiratory,Sterile Processing,Supply Chain,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190328T111500
DTEND;TZID=UTC:20190328T121500
DTSTAMP:20260505T031711
CREATED:20190220T035636Z
LAST-MODIFIED:20190329T011955Z
UID:10001633-1553771700-1553775300@education.healthtrustpg.com
SUMMARY:"Thromboembolism in Pregnancy"
DESCRIPTION:Download a copy of this content. \nAccess the recording. \nHealthTrust presents…”Thromboembolism in Pregnancy” (Part 4 in the Maternal Morbidity & Mortality 4-part series) \nMaternal mortality has increased precipitously in the United States over the past 15 years. Venous thromboembolism (VTE) is a leading cause of death during pregnancy\, accounting for approximately 10 percent of all maternal mortality. Timely diagnosis and treatment can prevent many of these tragedies. Similarly\, venous thromboembolism prophylaxis during pregnancy and the peripartum period can prevent a significant amount of these potentially catastrophic events. In this session\, the presenter will describe significant risk factors as well as recommendations for diagnosis\, management\, prevention and treatment of venous thromboembolism. A tailored\, multi-disciplinary approach including contributions from pharmacists\, nurses and lab clinicians is essential for successful outcomes in the treatment of thromboembolism in pregnancy. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDescribe the risk factors of thromboembolism in pregnancy\nExplain why pregnancy is a thrombogenic state\nRecall why peripartum venous thrombo prophylaxis can help prevent maternal deaths\nIdentify the benefits of utilizing an evidence-based care\, team approach to aid patients with venous thromboembolism (VTE)\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.\, FACOG | Chairman of the Department of Obstetrics & Gynecology | Moses Taylor Hospital \nTarget Audience: Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education: Approved for Nurses\, Pharmacists & Lab \nNote about CE credit: \n\n\n\n\n\n\n\nIf you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit.\nCE credit is individual. No group credit is available.\nEach person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit.\nAttendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. \nIf you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.\n\n\n\nVisit the On-Demand Learning section to access recordings from Parts 1–3: \n\nHigh Reliability & Safety in Obstetrics: A Life-saving Approach\nCode Crimson: Massive Transfusion Protocol\nHypertensive Disorders of Pregnancy
URL:https://education.healthtrustpg.com/calendar/thromboembolism-in-pregnancy/
CATEGORIES:Lab,Nursing,Pharmacy,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190215T111500
DTEND;TZID=UTC:20190215T121500
DTSTAMP:20260505T031711
CREATED:20190131T015003Z
LAST-MODIFIED:20190225T195818Z
UID:10000191-1550229300-1550232900@education.healthtrustpg.com
SUMMARY:"Hypertensive Disorders of Pregnancy"
DESCRIPTION:Download a copy of this content. \nAccess the recording. \nSupporting documents and procedures checklists. \nHealthTrust presents…“Hypertensive Disorders of Pregnancy” (Part 3 of 4 in the Maternal Morbidity & Mortality series) \nDespite a worldwide trend toward improvement in maternal morbidity and mortality\, rates in the U.S. have surged in recent years. Specifically\, the unacceptable rates of preventable adverse events in childbirth are topping 50 percent. A major reason for this tragic result is poor recognition and appropriate treatment of hypertensive disorders during pregnancy. This program will review the four major hypertensive disorders of obstetrics and focus on the rapid diagnosis and treatment of hypertensive emergencies—a major cause of maternal deaths. A tailored\, multi-disciplinary approach including contributions from pharmacists\, nurses and lab clinicians is essential for successful outcomes in the treatment of hypertensive disorders. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDescribe the four types of hypertension that can complicate pregnancy\nExplain the maternal and fetal complications that can result from hypertensive disorders of pregnancy\nRecall the evaluation\, diagnosis and management of hypertensive emergencies in pregnancy\nIdentify the benefits of utilizing an evidence-based care team approach to aid patients with hypertensive disorders\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.\, FACOG  | Chairman of the Department\, Obstetrics & Gynecology | Moses Taylor Hospital \nTarget Audience: Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education: Approved for Nurses\, Pharmacists & Lab \n\n\nNote about CE credit:  \n\nIf you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit.\nCE credit is individual. No group credit is available.\nEach person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit.\nAttendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. \nIf you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.\n\nWatch for upcoming topics in the Maternal Morbidity & Mortality Series: \n\nMarch 28\, 2019 – Thromboembolism\n\nAccess the On-Demand Learning section to listen to recordings from Part 1: High Reliability & Safety in Obstetrics: A Life-saving Approach and Part 2: Code Crimson: Massive Transfusion Protocol. \n 
URL:https://education.healthtrustpg.com/calendar/hypertensive-disorders-of-pregnancy/
CATEGORIES:Healthcare Executives,Lab,Nursing,Pharmacy,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190207T120000
DTEND;TZID=UTC:20190207T133000
DTSTAMP:20260505T031711
CREATED:20190112T005245Z
LAST-MODIFIED:20190112T030424Z
UID:10000168-1549540800-1549546200@education.healthtrustpg.com
SUMMARY:“Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations”
DESCRIPTION:Nova Biomedical* presents… “Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations” \nPart I: Clinical Consequences  |  “Venous\, arterial\, and now capillary specimens are all FDA cleared for testing critically ill patients – Are all specimen types analytically and clinically equivalent?” \nThe choice of specimen type is an important consideration\, particularly for critically ill patients. This presentation will cover the analytical performance differences between different specimen types and their clinical significance. The data is based on the results of an FDA comparison study of 16\,778 paired patients test results. \nPart I Learning Objectives: \n\nAnalytical performance differences\nClinical significance of these differences\nSuggested best practice testing procedures\n\nPart I presenter: \n \nJeffrey A. DuBois\, Ph.D.  |  VP of Medical and Scientific Affairs  |  Nova Biomedical \n*             *             *             *             * \nPart II: Regulatory/Legal Consequences  |  “Regulatory requirements for off-label testing and the consequences of non-compliance”“ \nOne meter is FDA cleared and CLIA waived for use with all patients including critically ill. Use of all other meters with any critically ill patient population is considered off label by FDA and CMS. Hospitals cannot change the FDA’s off-label testing designations using their own testing or definitions. This presentation will review the history and rationale for recent FDA changes to bedside glucose testing in critically ill patients and the regulatory and legal consequences of off-label testing for caregivers and hospitals. \nPart II Learning Objectives: \n\nThe history and rationale for the FDA’s requirements for off-label bedside glucose testing from 2010 to 2018\nUnderstand when bedside glucose testing is off-label\nFDA testing requirements for off-label bedside glucose testing\nPatient risks if off-label testing is used for critically ill patients\nCaregiver’s personal liability risks when performing off-label glucose testing\nHospital liability risks when performing off-label glucose testing\nCLIA risks when performing off-label glucose testing\n\nPart II Presenter: \n \nNatalia Mazina\, Esq. |  Compliance Attorney |  FDA \nContinuing education credits |  Lab and Nursing  |  This program is accredited by the Society for Clinical Laboratory Science\, American Association of Critical Care Nurses\, American Society for Health Care Risk Management\, and ACCENT to offer a total of 1.00 CE credit (1.00 max). \nQuestions should be directed to Nova Biomedical: (781) 894-0800 |  info@novabiomedical.com \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/consequences-of-fda-changes-to-critically-ill-bedside-glucose-testing-regulations/
CATEGORIES:Lab,Nursing
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190114T080000
DTEND;TZID=UTC:20190114T235900
DTSTAMP:20260505T031711
CREATED:20181210T193456Z
LAST-MODIFIED:20181214T192241Z
UID:10000167-1547452800-1547510340@education.healthtrustpg.com
SUMMARY:Deadline for 2019 HTU Proposals
DESCRIPTION:Tonight is the deadline to submit presentations for consideration as part of the 2019 HealthTrust University Conference education line up. \nSubmit proposals here by 11:59 PM (Central time). \n2019 HTU: August 12-14  |  Gaylord Opryland Resort & Convention Center  |   Nashville\, TN \n 
URL:https://education.healthtrustpg.com/calendar/deadline-for-2019-htu-presentations/
CATEGORIES:Cardiovascular,Facilities,Food & Nutrition,Healthcare Executives,Lab,Nursing,Pharmacy,Physicians,Radiology,Respiratory,Supply Chain,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190111T111500
DTEND;TZID=UTC:20190111T121500
DTSTAMP:20260505T031711
CREATED:20181210T223200Z
LAST-MODIFIED:20190220T192327Z
UID:10000170-1547205300-1547208900@education.healthtrustpg.com
SUMMARY:"Code Crimson: Massive Transfusion Protocol"
DESCRIPTION:Access the recording. \nDownload a copy of this content. \nSupporting Documents & Procedure Checklists \nHealthTrust presents…”Code Crimson: Massive Transfusion Protocol” (Part 2 of 4 in the Maternal Morbidity & Mortality series) \nThe U.S. rate of severe maternal morbidity at delivery\, as defined by a variety of conditions and procedures\, increased 45 percent from 2006 through 2015. The cause of this adverse trend is complex and multi-factorial. A significant place to start in combating the current epidemic of maternal mortality in the United States is appropriately addressing maternal hemorrhage. The presenter offers an evidenced-based approach to saving maternal lives when the inevitable life-threatening hemorrhage does occur. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDefine risk factors which contribute to catastrophic maternal hemorrhage\nRecall why massive transfusion protocols are physiologic and effective\nExplain the benefits of utilizing an evidence-based care team approach to aid patients in extremis\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.\, FACOG  |  Chairman of the Department\, Obstetrics & Gynecology  |  Moses Taylor Hospital \nTarget Audience:  Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education Information: 1.0 contact hours approved for Pharmacists\, Nurses and Lab professionals. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Belmont University School of Nursing is an approved provider of continuing nursing education by the Tennessee Nurses Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  The ACPE Universal Activity Number for this activity is 0863-0000-19-023-L04-P. HealthTrust is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. The activity is approved for 1 hour of continuing education credit to pharmacists\, nurses and lab professionals who attend the webinar and complete the online evaluation. \nNote about CE credit:  \n\nIf you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit.\nCE credit is individual. No group credit is available.\nEach person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit.\nAttendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. \nIf you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.\n\nWatch for upcoming topics in the Maternal Morbidity & Mortality Series: \n\nFeb. 15\, 2019 – Four Types of Hypertension in Obstetrics\nMarch 28\, 2019 – Thromboembolism\n\nView the November 29 calendar or the On-Demand Learning section to listen to a recording from Part 1: High Reliability & Safety in Obstetrics: A Life-saving Approach
URL:https://education.healthtrustpg.com/calendar/save-the-date-code-crimson-massive-transfusion-protocol/
CATEGORIES:Healthcare Executives,Lab,Nursing,Pharmacy,Physicians,Supply Chain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20190114
DTSTAMP:20260505T031711
CREATED:20181214T190716Z
LAST-MODIFIED:20181214T191935Z
UID:10000183-1544400000-1547423999@education.healthtrustpg.com
SUMMARY:2019 HTU Call for Proposals Is Open
DESCRIPTION:Speakers are invited to submit proposals for consideration as part of the 2019 HealthTrust University Conference education line up. \nSubmit proposals here by the Jan. 14 deadline (11:59 PM central time). \nInvite others from your facility or health system to share their clinical initiative outcomes or supply chain success stories. \nDownload a flyer to share the details \n  \n \n2019 HTU: August 12-14  |  Gaylord Opryland Resort & Convention Center  |   Nashville\, TN
URL:https://education.healthtrustpg.com/calendar/2019-htu-call-for-proposals-is-open/
CATEGORIES:Cardiovascular,Facilities,Food & Nutrition,Healthcare Executives,Lab,Nursing,Pharmacy,Physicians,Radiology,Respiratory,Supply Chain,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181205T120000
DTEND;TZID=UTC:20181205T130000
DTSTAMP:20260505T031711
CREATED:20181129T200827Z
LAST-MODIFIED:20181129T201256Z
UID:10001609-1544011200-1544014800@education.healthtrustpg.com
SUMMARY:“How I Recommend Flu Vaccine: How to Make Recommendations that Matter to Patients”
DESCRIPTION:The CDC & the Public Health Foundation* present…“How I Recommend Flu Vaccine: How to Make Recommendations that Matter to Patients” \nEvery year\, there are large numbers of Americans who get sick and die as a result of seasonal flu. Yet\, many of your patients may underestimate flu’s severity or their own susceptibility to catching the flu. If patients don’t understand that they are at risk and that risk could be serious\, they may not prioritize getting their seasonal flu vaccines. Healthcare professionals are the most trusted source of health information for patients\, and your recommendations make a difference when it comes to flu vaccination rates. You may already be recommending flu vaccine to your patients\, but in this webinar\, you’ll get tips on how to make even stronger and more effective recommendations. You’ll also learn how to answer many important questions from patients. \nObjectives: \n\nUnderstand burden and severity of last year’s flu season\nDescribe flu vaccine benefits\, including potential flu burden averted by vaccination\nDescribe how to make a strong and effective flu vaccine recommendation to patients and why your recommendation matters\nIllustrate how to properly administer flu vaccine\n\nSpeakers: \n\nMelissa Rolfes\, Ph.D.\, MPH  |  Epidemiologist  |  Influenza Division  |  National Center for Immunization and Respiratory Diseases\, CDC\nSandra Leal\, PharmD\, MPH\, FAPhA  |  Pharmacist & Certified Diabetes Educator |  SinfoníaRx\nJoEllen Wolicki\, BSN\, RN  |  Nurse Educator  |  Immunization Services Division  |  NCIRD\, CDC\n\nTarget Audience: All professionals interested in learning more about immunizations are welcome to attend\, but registration is required. Please click here to register. there is no CE credit associated with attending this webinar. \nSubmit your question(s) to the immunization experts in advance via email to webinars@phf.org. \nFor more information\, please contact the Public Health Foundation’s Kathleen Amos at kamos@phf.org. \n* NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/how-i-recommend-flu-vaccine-how-to-make-recommendations-that-matter-to-patients/
CATEGORIES:Healthcare Executives,Lab,Nursing,Pharmacy,Physicians,Respiratory
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181129T120000
DTEND;TZID=UTC:20181129T130000
DTSTAMP:20260505T031711
CREATED:20181117T034030Z
LAST-MODIFIED:20181117T034030Z
UID:10001605-1543492800-1543496400@education.healthtrustpg.com
SUMMARY:"Implementing Next-generation Sequencing for Precision Oncology Testing"
DESCRIPTION:Fisher Scientific* presents….”Implementing Next-generation Sequencing for Precision Oncology Testing” \nAccording to a recent study by the Tufts Center for the Study of Drug Development\, the majority of cancer treatments in development have an associated genomic biomarker—a trend that’s expected to increase in the coming years. With this evolution in the clinical oncology landscape\, academic medical centers and hospital systems alike have adopted diagnostic precision medicine tools like next generation sequencing (NGS)\, which enables labs to rapidly and simultaneously test multiple genomic biomarkers from just a few nanograms of precious tumor tissue.  As the number of clinically significant biomarkers continues to expand\, this testing will continue to play a critical role in cancer diagnosis and treatment. \nIn this P.A.C.E.-accredited webinar\, Brian Piening\, Phd\, will highlight the clinical and economic considerations for implementing an NGS-based personalized medicine program and discuss case studies that demonstrate the benefits of determining the genomic profiles of a variety of cancer types. \nLearning Objectives: \n\nEvaluate the process of deciding whether to implement NGS in a clinical pathology lab\nDescribe the available testing strategies and chemistries\nReview case studies in which NGS is uniquely suited to provide novel clinical insights\n\nPresenter: \n \nBrian Piening\, Ph.D. | Associate Director | Providence St. Joseph Health (PSJH) Molecular Genomics Laboratory | Assistant Member and Head of the Tumor Immunogenomics Laboratory | Earle A. Chiles Research Institute & Providence Cancer Center \nThis webinar is produced by Whitehat Communications\, a provder of continuing education programs i clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary\, basic-level program. \nUnless otherwise noted\, P.A.C.E. accreditation will expire six months after the live webinar. \n*NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/implementing-next-generation-sequencing-for-precision-oncology-testing/
CATEGORIES:Healthcare Executives,Lab,Nursing,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181129T120000
DTEND;TZID=UTC:20181129T130000
DTSTAMP:20260505T031711
CREATED:20181023T173113Z
LAST-MODIFIED:20190220T192421Z
UID:10001565-1543492800-1543496400@education.healthtrustpg.com
SUMMARY:"High Reliability & Safety in Obstetrics: A Life-saving Approach"
DESCRIPTION:Access the recording. \nDownload a copy of this content. \nSupporting Documents & Procedure Checklists \nHealthTrust presents…“High Reliability & Safety in Obstetrics: A Life-saving Approach” (Part 1 of 4 in the Maternal Morbidity & Mortality series) \nThe proportion of women who experienced serious complications while giving birth in U.S. hospitals rose drastically between 2006 and 2015. The difference in healthcare provider beliefs about autonomy\, teamwork and administrative operations have added to the complexity of healthcare delivery and are a central factor in medicine’s unacceptably high rate of errors. It is important to recognize that standardization is necessary\, but not always sufficient for achieving resilient and reliable healthcare systems. This presentation offers a specific pathway to significantly decrease the epidemic of maternal mortality and morbidity in the United States. The presenter will focus on practical concepts for highly reliable\, effective team collaboration to deliver safer care to obstetrics patients. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nDiscuss the concept of high reliability that could be replicated\nat any healthcare organization\nExplain the foundations of team culture as it relates to institutions that\nprioritize patient safety\nDefine the pillars upon which highly reliable clinical systems of care are built\n\nPresenter: \n \nFrank R. Kolucki\, Jr.\, M.D.\, FACOG  |  Chairman of the Department\, Obstetrics & Gynecology  |  Moses Taylor Hospital \nTarget Audience:  Physicians\, Nurses\, Pharmacists & Lab \nContinuing Education Information: 1.0 contact hours for Pharmacists and Nurses. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Belmont University School of Nursing is an approved provider of continuing nursing education by the Tennessee Nurses Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  The ACPE Universal Activity Number for this activity is 0863-0000-18-103-L05-P. The activity will provide 1 hour of continuing education credit to pharmacists and nurses who attend the webinar and complete the online evaluation. \nNote: No group credit is available. HealthTrust’s CE credit provider requires that each participant register and join the actual webinar event individually. \nWatch for upcoming topics in the Maternal Morbidity & Mortality Series: \n\nJan. 2019 – Massive Transfusion Protocol\nFeb. 2019 – Hypertension\nMarch 2019 – Thromboembolism
URL:https://education.healthtrustpg.com/calendar/save-the-date-maternal-morbidity-mortality-4-part-series-part-1-high-reliability-safety-in-obstetrics-a-life-saving-approach/
CATEGORIES:Lab,Nursing,Pharmacy,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181120T080000
DTEND;TZID=UTC:20181120T170000
DTSTAMP:20260505T031711
CREATED:20181121T004335Z
LAST-MODIFIED:20181121T004739Z
UID:10001607-1542700800-1542733200@education.healthtrustpg.com
SUMMARY:"Infectious Waste DOT Certification"
DESCRIPTION:Daniel’s Health* presents…”Infection Waste DOT Certification”\n \nDid you know that anyone who is packaging or transporting waste within a healthcare facility is required to be certified for DOT RMW Training?  Attend this free session for DOT certification on Infectious Substances. \nLearning Objectives | At the completion of this activity\, the participant will be able to: \n\nClassify and name medical wastes\nUnderstand how to properly package\, mark and label medical waste containers\nComplete proper shipping documentation for medical waste\nMeet Department of Transportation requirements for training\nReceive a certificate of completion\n\nPresenter: \nAshley Perry | Hazardous Waste & Compliance Specialist | Daniel’s Health \n* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/infectious-waste-dot-certification/
CATEGORIES:Facilities,Lab,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181119T130000
DTEND;TZID=UTC:20181119T140000
DTSTAMP:20260505T031711
CREATED:20181106T054014Z
LAST-MODIFIED:20181106T215317Z
UID:10001594-1542632400-1542636000@education.healthtrustpg.com
SUMMARY:"Innovation in Sepsis Diagnostics & Treatment"
DESCRIPTION:The Sepsis Coordinator Network *  presents…”Innovation in Sepsis  Diagnostics & Treatment” \nLearn about some of the latest innovations in sepsis diagnostics and treatment. \nObjectives: \n\nDiscuss the role that fast diagnostics for bloodstream infections play in expediting treatment of patients.\nDefine the role of GIAPREZA in treating patients with septic or other distributive shock\nRecall patient-focused medical innovations for critical care monitoring\n\nPresenters: \n \nJulie Butt\, RN\, BSN OCN | Clinical Nurse Educator | La Jolla Pharmaceuticals \n \nMaureen Spencer\, M.ED\, BSN\, RN\, CIC\, FAPIC | Director\, Clinical Implementation | Accelerate Diagnostics \n \nNora O’Buck\, RN-BSN\, CCRN | Program Manager\, Professional Education | Edwards Lifesciences \nPlease submit any questions to: smcmannus@sepsis.org \n* NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/sepsis-coordinator-network-sponsor-innovation-webinar/
CATEGORIES:Lab,Nursing,Physicians
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20181114T113000
DTEND;TZID=UTC:20181114T123000
DTSTAMP:20260505T031711
CREATED:20181002T175803Z
LAST-MODIFIED:20181117T010344Z
UID:10001522-1542195000-1542198600@education.healthtrustpg.com
SUMMARY:"USP /: Cleanroom Design & Environmental Monitoring"
DESCRIPTION:Access the recording. \nDownload a copy of this presentation. \nHealthTrust & TechSafety present…”USP <797>/<800>: Cleanroom Design & Environmental Monitoring” \nWhile USP (United States Pharmacopeia) <797> previously established requirements for hazardous drug compounding\, its latest revision—<800>—clarifies and expands upon sterile and non-sterile hazardous drug compounding. Enhanced engineering and procedural controls extend protection to operators and environments when packaging\, handling and compounding hazardous substances (including 2018 updates to the National Institute for Occupational Safety and Health list). Many sterile compounding pharmacies are unfamiliar with the certification requirements for their facilities and are unsure how to interpret the data they receive from testing. This presentation will provide a background to the creation of USP chapters <797> and <800>\, describe the cleanroom requirements for both hazardous and non-hazardous sterile compounding areas\, describe the testing requirements to demonstrate compliance and review corrective actions for areas commonly found to be non-compliant. \nLearning Objectives for Pharmacist member attendees: \nAt the end of this session\, participants should be able to: \n\nDiscuss the requirements for environmental controls in sterile compounding environments.\nRecall the required tests to prove compliance with USP <797> & <800>.\nPlan corrective actions for non-compliance issues often found in sterile compounding clean areas.\n\n Learning Objectives for Pharmacy Technician member attendees: \nAt the end of this session\, participants should be able to: \n\nDefine the environmental controls required to maintain sterility in USP <797> compliant cleanrooms.\nRecall principles of Environmental Monitoring and Personnel Monitoring as it relates to USP <797>.\n\nPresenter: \n \nAndrew King\, RCCP-SCF\, is the USP <797> specialist  at Technical Safety Services\, LLC. He is accredited as a Registered Cleanroom Certification Professional for Sterile Compounding Facilities.  King’s focus is on certification and compliance for sterile compounding cleanrooms and equipment.  He earned his undergraduate degree from the University of Rochester. \nTarget Audience:  Pharmacists and Pharmacy Technicians: \nContinuing Education Information: 1.0 contact hours for Pharmacists and Pharmacy Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-0000-18-101-L07-P and 0863-0000-18-101-L07-T. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists and technicians who attend the webinar and complete the online evaluation. \nNote: No group credit is available. HealthTrust’s CE credit provider requires that each participant register and join the actual webinar event individually. \n 
URL:https://education.healthtrustpg.com/calendar/usp-cleanroom-design-environmental-monitoring/
CATEGORIES:Lab,Pharmacy
END:VEVENT
END:VCALENDAR